Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
In conclusion, we developed a pan-inhibitor targeting tumors with different IDH1R132 mutations.
Source: Acta Neuropathologica - Category: Neurology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Astrocytoma | Bile Duct Cancer | Brain Tumor | Cholangiocarcinoma | Chondrosarcoma | Glioma | Leukemia | Neurology | Toxicology | Transplants